Invega® Significantly Reduced Symptoms Of Schizophrenia In Acutely Ill, Hospitalised Patients Compared To Quetiapine
Yesterday, Janssen-Cilag presented for the first time in Europe, new preliminary data that show acutely ill, hospitalised patients with schizophrenia experienced significant improvement in symptoms after taking INVEGA® (paliperidone prolonged-release tablets) as compared to Seroquel® (quetiapine) or placebo. [click link for full article]
Recent Comments